E156 Micro-Paper · Africa Clinical Trials

Substance Use Disorders

Alcohol use disorders alone account for 4% of Africa's disease burden, yet addic...

Africa Trials
28
US Trials
5,012
Gap Ratio
179x
Nations
54
Key Finding
Africa hosted 28 alcohol trials versus 5,012 in the United States, a 179-fold disparity in research investment.
Regional Comparison
Burden vs Investment 0 1000 2000 3000 4000 5000 50000 100000 150000 Africa US Europe
Substance Use Disorders Lorenz Curve 0% 0% 25% 25% 50% 50% 75% 75% 100% 100% Gini = 0.711
Distribution Analysis
Substance Use Disorders by Country Egypt: 11752 Algeria: N/A Morocco: 162 Tunisia: 540 Senegal: N/A Ghana: 261 Nigeria: 379 Cameroon: N/A DRC: N/A Ethiopia: 302 Kenya: 788 Uganda: 809 Tanzania: 460 Rwanda: N/A South Africa: 3654 Egy 11752 Sou 3654 Uga 809 Ken 788 Tun 540 162 11752
No data
Inequality Profile
Contribution Breakdown 11752 Egypt 3654 South Afri 809 Uganda 788 Kenya 540 Tunisia 2814 Others
Research Profile Volume Growth Phase3 Complete Diversity
Temporal & Structural
Enrollment Distribution Africa Reference 2000 4000 6000
Enrollment Density Africa Reference 5000 10000
Why It Matters

Alcohol use disorders alone account for 4% of Africa's disease burden, yet addiction medicine trials are virtually absent from the continent's research portfolio.

The Evidence   133 words · target 156
In the burden-versus-investment landscape of African health research, does the distribution of alcohol trials across African nations reveal a systematic research gap? This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.gov through April 2026. Investigators computed the Spearman rank correlation as the primary estimand using registry metadata for each nation. Africa hosted 28 alcohol trials (0.1% of its portfolio) compared to 5,012 in the United States, yielding a 0.0-fold disparity in per-population investment. Temporal analysis showed 17.1-fold growth in African trial registrations from 2000-2005 to 2021-2025, though the gap with high-income regions persisted. These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa. Interpretation is constrained by missing sub-national data and the exclusion of observational studies from the analysis.
Sentence Structure
Question

In the burden-versus-investment landscape of African health research, does the distribution of alcohol trials across African nations reveal a systematic research gap?

Dataset

This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.

Method

gov through April 2026.

Primary Result

Investigators computed the Spearman rank correlation as the primary estimand using registry metadata for each nation.

Robustness

Africa hosted 28 alcohol trials (0.

Interpretation

1% of its portfolio) compared to 5,012 in the United States, yielding a 0.

Boundary

0-fold disparity in per-population investment.

Extra

Temporal analysis showed 17.

Extra

1-fold growth in African trial registrations from 2000-2005 to 2021-2025, though the gap with high-income regions persisted.

Extra

These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa.

Extra

Interpretation is constrained by missing sub-national data and the exclusion of observational studies from the analysis.

Back to Group Download Code (.py) GitHub